FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

AJ Mead, DC Linch, Robert Hills, Keith Wheatley, AK Burnett, RE Gale

Research output: Contribution to journalArticle

215 Citations (Scopus)

Fingerprint

Dive into the research topics of 'FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science